Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-05-23
1997-01-14
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544262, C07D23970, A61K 31415
Patent
active
055939970
ABSTRACT:
Certain 4-aminopyrazolo[3,4-d]pyrimidine compounds, and their pharmaceutically-acceptable salts and prodrugs, are inhibitors of tyrosine kinase enzymes and are useful for immunoregulation and for the treatment of cancer, angiogenesis and atherosclerosis.
REFERENCES:
patent: 4044130 (1977-08-01), Howarth et al.
Tominaga, Y, "Synthesis . . . ", Journal of Heterocylic Chem., 27, 647-60, (1989).
Gatta, F., "Pyrazolo . . . ", J. Heterocyclic Chem., 26, 613 (1989).
Tominaga, Y, "Synthesis . . . ", Journal of Heterocyclic Chem., 27, 647-60, (1989).
Dow Robert L.
Koch Kevin
Schulte Gary R.
Benson Gregg C.
Bottino Anthony
Olson A. Dean
Pfizer Inc.
Richardson Peter C.
LandOfFree
4-aminopyrazolo(3-,4-D)pyrimidine and 4-aminopyrazolo-(3,4-D)pyr does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 4-aminopyrazolo(3-,4-D)pyrimidine and 4-aminopyrazolo-(3,4-D)pyr, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-aminopyrazolo(3-,4-D)pyrimidine and 4-aminopyrazolo-(3,4-D)pyr will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1388409